Home
About
FAQ
History (9)
Re: Mutations in TERT Promoter and FGFR3 and Telomere Length in Bladder Cancer.
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.
Purging of malignant cell contamination prior to spermatogonia stem cell autotransplantation to preserve fertility: progress & prospects.
Extending life using tissue and organ replacement.
Re: bispecific small molecule-antibody conjugate targeting prostate cancer.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Re: bispecific small molecule-antibody conjugate targeting prostate cancer.
Atala A. Re: bispecific small molecule-antibody conjugate targeting prostate cancer. J Urol. 2014 Jun; 191(6):1927-8.
View in:
PubMed
subject areas
Animals
Drug Discovery
Humans
Immunoglobulin Fab Fragments
Male
Prostatic Neoplasms
authors with profiles
Anthony Atala MD